AIV Logo AIV Assistant

Loading...

Logo Hims & Hers Health, Inc. - HIMS Open Hims & Hers Health, Inc. in new tab

41.52 USD
P/E
57.54
EPS
0.79
P/B
18.24
ROE
41.88
Beta
2.25
Target Price
47.77 USD
Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc.

🧾 Earnings Recap – Q3 2025

Hims & Hers reported a robust Q3 2025, achieving nearly 50% year-over-year revenue growth driven by a 50% increase in subscribers using personalized health solutions, bolstered by strategic partnerships and innovations.

  • Subscribers utilizing personalized care solutions surged 50% year-over-year, underpinning revenue growth.
  • Strategic partnerships with Novo Nordisk and Marius Pharmaceuticals aim to expand access to innovative treatments, including Wegovy.
  • The company made a significant investment in GRAIL, enhancing its offerings in multi-cancer early detection.
  • A strategic reduction in GLP-1 treatment prices by up to 20% aims to broaden care accessibility.
  • Ongoing verticalization of compounding operations is expected to improve efficiency and quality in service delivery.
📅

41.5200 USD

41.520 USD

Daily: -5.05%
Key Metrics

Earnings date: Feb. 23, 2026

P/E: 57.54

EPS: 0.79

Book Value: 2.49

Price to Book: 18.24

Debt/Equity: 185.60

% Insiders: 6.341%

Growth

Revenue Growth: 0.73%

Earnings Growth: 1.98%

Estimates

Forward P/E: 98.83

Forward EPS: 0.46

Target Mean Price: 47.77

DCF Valuation

Tweak assumptions to recompute fair value for Hims & Hers Health, Inc. (HIMS)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Logo About Hims & Hers Health, Inc. - (HIMS)

Country: United States

Sector: Consumer Staples

Website: http://www.forhims.com

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Exchange Ticker
NYQ (United States) HIMS

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion